← All organizations

Japan Multinational Trial Organization

Academic/HospitalWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 1, 2007

Timeline

1990s

Feb 1, 1992
Japan Multinational Trial Organization— Founded

Drugs by trial phase (10 distinct, 4 trials)

Phase 3 (8 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

irinotecan

Phase 1 (1 own, 0 via acquisition)

amrubicin

Indications

Studied for

Recent trials (5)

NCT00508690Lead sponsorPhase 3Sep 1, 2007
NCT00508690Reponsible party - principal investigatorPhase 3Sep 1, 2007
NCT00132054Lead sponsorPhase 1May 1, 2004
NCT00104793Lead sponsorPhase 2Jun 1, 2003
NCT00079287Lead sponsorPhase 3Mar 1, 2001

Details

Founded: Nagoya, JP Feb 1, 1992
Last known activity: Sep 1, 2007